Details for New Drug Application (NDA): 013416
✉ Email this page to a colleague
NDA 013416 describes NORGESIC FORTE, which is a drug marketed by Bausch and is included in one NDA. Additional details are available on the NORGESIC FORTE profile page.
The generic ingredient in NORGESIC FORTE is aspirin; caffeine; orphenadrine citrate. There are twenty-two drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the aspirin; caffeine; orphenadrine citrate profile page.
The generic ingredient in NORGESIC FORTE is aspirin; caffeine; orphenadrine citrate. There are twenty-two drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the aspirin; caffeine; orphenadrine citrate profile page.
Summary for 013416
| Tradename: | NORGESIC FORTE |
| Applicant: | Bausch |
| Ingredient: | aspirin; caffeine; orphenadrine citrate |
| Patents: | 0 |
Profile for product number 003
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 385MG;30MG;25MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | ||||
| Approval Date: | Oct 27, 1982 | TE: | RLD: | Yes | |||||
Profile for product number 004
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 770MG;60MG;50MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | ||||
| Approval Date: | Oct 27, 1982 | TE: | RLD: | Yes | |||||
Complete Access Available with Subscription
